Orbital, Aktina sign distribution deal

Orbital Therapy has entered into agreement with Aktina Medical to distribute its ClearVue prone breast radiotherapy table in the United States.

The ClearVue table is a recent addition to the Bedford-Mass.-based breast cancer treatment manufacturer’s product line. Orbital Therapy said that the table places the patient in the prone position and increases the separation between the target anatomy and critical structures.

The product is currently in use in the United States and Europe.

Both companies will be showcasing the system at the 2009 American Society for Radiation Oncology (ASTRO) conference in Chicago.

Around the web

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.